FiercePharma4h
Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Teva price target raised to $30 from $28 at UBS
UBS raised the firm’s price target on Teva (TEVA) to $30 from $28 and keeps a Buy rating on the shares. Teva, one of the firm’s top picks for ...
Teva Pharmaceuticals: Promising Growth Prospects and Buy Rating Reaffirmed
Bank of America Securities analyst Jason Gerberry has reiterated their bullish stance on TEVA stock, giving a Buy rating on January 21.Invest ...
Diversify Advisory Services LLC Purchases 496 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Diversify Advisory Services LLC raised its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 2.5% during the fourth quarter, according to its most recent ...
The American Journal of Managed Care17h
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction, linked to ...
devdiscourse19h
Global Health News: Abroad and in Focus
Recent news highlights include Hong Kong shareholders rejecting Fosun's buyout of Henlius Biotech, Abbott focusing on glucose monitors amidst currency woes, FDA warning on multiple sclerosis drugs, ...
Managed Healthcare Executive19h
FDA Adds Boxed Warning to MS Drug Copaxone
Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated ...
JD Supra21h
Precedential Federal Circuit Decision Overturns Lack of Written Description Based on Later-Discovered Technology
On January 10, 2025, the US Court of Appeals for the Federal Circuit issued a precedential opinion in Novartis Pharmaceuticals Corp. v. Torrent ...
The Pharma Letter23h
FDA warns of rare but serious allergic reaction with glatiramer
The US Food and Drug Administration (FDA) is warning about the risk of a rare but serious allergic reaction with the medicine ...
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
Future Market Insights1d
Small-Molecule Injectable Industry to Reach USD 131.7 Billion by 2033, Growing at a 7.3% CAGR
The global small-molecule injectable market is projected to grow at a 7.3% CAGR, reaching USD 131.70 billion by 2033. Rising ...
Women's Health Market Set To Grow 4.8% Annually Through 2033
Women's Health Market size is expected to reach US$ 66 Billion by 2033, from US$ 41.3 Billion in 2023, growing at a CAGR of 4.8%. Lawrence John Prudour +91 91308 55334 ...